Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Cullinan Therapeutics (CGEM) Leases (2022 - 2023)

Cullinan Therapeutics (CGEM) has 2 years of Leases data on record, last reported at $2.9 million in Q3 2023.

  • For Q3 2023, Leases fell 34.94% year-over-year to $2.9 million; the TTM value through Sep 2023 reached $2.9 million, down 34.94%, while the annual FY2022 figure was $4.1 million, N/A changed from the prior year.
  • Leases reached $2.9 million in Q3 2023 per CGEM's latest filing, down from $3.5 million in the prior quarter.
  • Across five years, Leases topped out at $4.5 million in Q3 2022 and bottomed at $1.1 million in Q2 2022.